Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Apr 15;97(8):1900–1907. doi: 10.1172/JCI118621

Primary preventive and secondary interventionary effects of acetyl-L-carnitine on diabetic neuropathy in the bio-breeding Worcester rat.

A A Sima 1, H Ristic 1, A Merry 1, M Kamijo 1, S A Lattimer 1, M J Stevens 1, D A Greene 1
PMCID: PMC507259  PMID: 8621774

Abstract

The abnormalities underlying diabetic neuropathy appear to be multiple and involve metabolic neuronal and vasomediated defects. The accumulation of long-chain fatty acids and impaired beta-oxidation due to deficiencies in carnitine and/or its esterified derivatives, such as acetyl-L-carnitine, may have deleterious effects. In the present study, we examined, in the diabetic bio-breeding Worcester rat, the short- and long-term effects of acetyl-L-carnitine administration on peripheral nerve polyols, myoinositol, Na+/K+ -ATPase, vasoactive prostaglandins, nerve conduction velocity, and pathologic changes. Short-term prevention (4 mo) with acetyl-L-carnitine had no effects on nerve polyols, but corrected the Na+/K+ -ATPase defect and was associated with 63% prevention of the nerve conduction defect and complete prevention of structural changes. Long-term prevention (8 mo) and intervention (from 4 to 8 mo) with acetyl-L-carnitine treatment normalized nerve PGE(1) whereas 6-keto PGF(1-alpha) and PGE(2) were unaffected. In the prevention study, the conduction defect was 73% prevented and structural abnormalities attenuated. Intervention with acetyl-L-carnitine resulted in 76% recovery of the conduction defect and corrected neuropathologic changes characteristic of 4-mo diabetic rats. Acetyl-L-carnitine treatment promoted nerve fiber regeneration, which was increased two-fold compared to nontreated diabetic rats. These results demonstrate that acetyl-L-carnitine has a preventive effect on the acute Na+/- K+_ATPase defect and a preventive and corrective effect on PGE1 in chronically diabetic nerve associated with improvements of nerve conduction velocity and pathologic changes.

Full Text

The Full Text of this article is available as a PDF (216.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bunn H. F., Higgins P. J. Reaction of monosaccharides with proteins: possible evolutionary significance. Science. 1981 Jul 10;213(4504):222–224. doi: 10.1126/science.12192669. [DOI] [PubMed] [Google Scholar]
  2. Cameron N. E., Cotter M. A., Robertson S. Essential fatty acid diet supplementation. Effects on peripheral nerve and skeletal muscle function and capillarization in streptozocin-induced diabetic rats. Diabetes. 1991 May;40(5):532–539. doi: 10.2337/diab.40.5.532. [DOI] [PubMed] [Google Scholar]
  3. Cameron N. E., Cotter M. A. The relationship of vascular changes to metabolic factors in diabetes mellitus and their role in the development of peripheral nerve complications. Diabetes Metab Rev. 1994 Oct;10(3):189–224. doi: 10.1002/dmr.5610100302. [DOI] [PubMed] [Google Scholar]
  4. Corr P. B., Gross R. W., Sobel B. E. Amphipathic metabolites and membrane dysfunction in ischemic myocardium. Circ Res. 1984 Aug;55(2):135–154. doi: 10.1161/01.res.55.2.135. [DOI] [PubMed] [Google Scholar]
  5. Cotter M. A., Dines K. C., Cameron N. E. Prevention and reversal of motor and sensory peripheral nerve conduction abnormalities in streptozotocin-diabetic rats by the prostacyclin analogue iloprost. Naunyn Schmiedebergs Arch Pharmacol. 1993 May;347(5):534–540. doi: 10.1007/BF00166747. [DOI] [PubMed] [Google Scholar]
  6. Dyck P. J., Karnes J. L., O'Brien P., Okazaki H., Lais A., Engelstad J. The spatial distribution of fiber loss in diabetic polyneuropathy suggests ischemia. Ann Neurol. 1986 May;19(5):440–449. doi: 10.1002/ana.410190504. [DOI] [PubMed] [Google Scholar]
  7. Greene D. A., Sima A. A., Stevens M. J., Feldman E. L., Killen P. D., Henry D. N., Thomas T., Dananberg J., Lattimer S. A. Aldose reductase inhibitors: an approach to the treatment of diabetic nerve damage. Diabetes Metab Rev. 1993 Oct;9(3):189–217. doi: 10.1002/dmr.5610090304. [DOI] [PubMed] [Google Scholar]
  8. Ido Y., McHowat J., Chang K. C., Arrigoni-Martelli E., Orfalian Z., Kilo C., Corr P. B., Williamson J. R. Neural dysfunction and metabolic imbalances in diabetic rats. Prevention by acetyl-L-carnitine. Diabetes. 1994 Dec;43(12):1469–1477. doi: 10.2337/diab.43.12.1469. [DOI] [PubMed] [Google Scholar]
  9. Johnson P. C., Doll S. C., Cromey D. W. Pathogenesis of diabetic neuropathy. Ann Neurol. 1986 May;19(5):450–457. doi: 10.1002/ana.410190505. [DOI] [PubMed] [Google Scholar]
  10. Lowitt S., Malone J. I., Salem A., Kozak W. M., Orfalian Z. Acetyl-L-carnitine corrects electroretinographic deficits in experimental diabetes. Diabetes. 1993 Aug;42(8):1115–1118. doi: 10.2337/diab.42.8.1115. [DOI] [PubMed] [Google Scholar]
  11. Medori R., Autilio-Gambetti L., Jenich H., Gambetti P. Changes in axon size and slow axonal transport are related in experimental diabetic neuropathy. Neurology. 1988 Apr;38(4):597–601. doi: 10.1212/wnl.38.4.597. [DOI] [PubMed] [Google Scholar]
  12. Pugliese G., Tilton R. G., Williamson J. R. Glucose-induced metabolic imbalances in the pathogenesis of diabetic vascular disease. Diabetes Metab Rev. 1991 Mar;7(1):35–59. doi: 10.1002/dmr.5610070106. [DOI] [PubMed] [Google Scholar]
  13. Rogers S. P., Larkins R. G. Production of 6-oxo-prostaglandin F1 alpha and prostaglandin E2 by isolated glomeruli from normal and diabetic rats. Br Med J (Clin Res Ed) 1982 Apr 24;284(6324):1215–1217. doi: 10.1136/bmj.284.6324.1215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sima A. A., Bouchier M., Christensen H. Axonal atrophy in sensory nerves of the diabetic BB-Wistar rat: a possible early correlate of human diabetic neuropathy. Ann Neurol. 1983 Mar;13(3):264–272. doi: 10.1002/ana.410130307. [DOI] [PubMed] [Google Scholar]
  15. Sima A. A., Bril V., Nathaniel V., McEwen T. A., Brown M. B., Lattimer S. A., Greene D. A. Regeneration and repair of myelinated fibers in sural-nerve biopsy specimens from patients with diabetic neuropathy treated with sorbinil. N Engl J Med. 1988 Sep 1;319(9):548–555. doi: 10.1056/NEJM198809013190905. [DOI] [PubMed] [Google Scholar]
  16. Sima A. A., Brismar T. Reversible diabetic nerve dysfunction: structural correlates to electrophysiological abnormalities. Ann Neurol. 1985 Jul;18(1):21–29. doi: 10.1002/ana.410180105. [DOI] [PubMed] [Google Scholar]
  17. Sima A. A., Lattimer S. A., Yagihashi S., Greene D. A. Axo-glial dysjunction. A novel structural lesion that accounts for poorly reversible slowing of nerve conduction in the spontaneously diabetic bio-breeding rat. J Clin Invest. 1986 Feb;77(2):474–484. doi: 10.1172/JCI112326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sima A. A., Nathaniel V., Bril V., McEwen T. A., Greene D. A. Histopathological heterogeneity of neuropathy in insulin-dependent and non-insulin-dependent diabetes, and demonstration of axo-glial dysjunction in human diabetic neuropathy. J Clin Invest. 1988 Feb;81(2):349–364. doi: 10.1172/JCI113327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Sima A. A., Prashar A., Zhang W. X., Chakrabarti S., Greene D. A. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. J Clin Invest. 1990 May;85(5):1410–1420. doi: 10.1172/JCI114585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Sonobe M., Yasuda H., Hisanaga T., Maeda K., Yamashita M., Kawabata T., Kikkawa R., Taniguchi Y., Shigeta Y. Amelioration of nerve Na(+)-K(+)-ATPase activity independently of myo-inositol level by PGE1 analogue OP-1206.alpha-CD in streptozocin-induced diabetic rats. Diabetes. 1991 Jun;40(6):726–730. doi: 10.2337/diab.40.6.726. [DOI] [PubMed] [Google Scholar]
  21. Taglialatela G., Angelucci L., Ramacci M. T., Werrbach-Perez K., Jackson G. R., Perez-Polo J. R. Acetyl-L-carnitine enhances the response of PC12 cells to nerve growth factor. Brain Res Dev Brain Res. 1991 Apr 24;59(2):221–230. doi: 10.1016/0165-3806(91)90102-o. [DOI] [PubMed] [Google Scholar]
  22. Williamson J. R., Arrigoni-Martelli E. The roles of glucose-induced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes-induced vascular dysfunction. Int J Clin Pharmacol Res. 1992;12(5-6):247–252. [PubMed] [Google Scholar]
  23. Williamson J. R., Chang K., Frangos M., Hasan K. S., Ido Y., Kawamura T., Nyengaard J. R., van den Enden M., Kilo C., Tilton R. G. Hyperglycemic pseudohypoxia and diabetic complications. Diabetes. 1993 Jun;42(6):801–813. doi: 10.2337/diab.42.6.801. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES